These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 19418648

  • 21. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
    Schultze-Werninghaus G.
    Med Klin (Munich); 2002 Dec 15; 97 Suppl 2():1. PubMed ID: 12593173
    [No Abstract] [Full Text] [Related]

  • 22. Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease.
    Hoshino M, Ohtawa J.
    Respirology; 2011 Jan 15; 16(1):95-101. PubMed ID: 20920142
    [Abstract] [Full Text] [Related]

  • 23. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct 31; 144(44):55. PubMed ID: 12494604
    [No Abstract] [Full Text] [Related]

  • 24. Labeling changes for asthma drug salmeterol.
    FDA Consum; 2003 Oct 31; 37(6):6. PubMed ID: 14983813
    [No Abstract] [Full Text] [Related]

  • 25. Prevention of death in COPD.
    Duerden M.
    N Engl J Med; 2007 May 24; 356(21):2212; author reply 2213-4. PubMed ID: 17526087
    [No Abstract] [Full Text] [Related]

  • 26. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
    Akazawa M, Hayflinger DC, Stanford RH, Blanchette CM.
    Am J Manag Care; 2008 Jul 24; 14(7):438-48. PubMed ID: 18611095
    [Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
    Oba Y.
    Am J Manag Care; 2009 Apr 24; 15(4):226-32. PubMed ID: 19355795
    [Abstract] [Full Text] [Related]

  • 28. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
    Vestbo J.
    Ugeskr Laeger; 2004 Jan 19; 166(4):271-4. PubMed ID: 14964108
    [No Abstract] [Full Text] [Related]

  • 29. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 30. Combined salmeterol and fluticasone for COPD.
    Khamis RY, Rajakulasingam RK.
    Lancet; 2003 May 10; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
    [No Abstract] [Full Text] [Related]

  • 31. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
    Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R.
    Thorax; 2010 Jan 10; 65(1):39-43. PubMed ID: 20029037
    [Abstract] [Full Text] [Related]

  • 32. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999 Jan 10; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract] [Full Text] [Related]

  • 33. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
    Clin Ther; 2009 May 10; 31(5):1056-63. PubMed ID: 19539106
    [Abstract] [Full Text] [Related]

  • 34. Combined salmeterol and fluticasone for COPD.
    MacAllister R.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747902
    [No Abstract] [Full Text] [Related]

  • 35. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 36. Combined salmeterol and fluticasone for COPD.
    Pakhale SS, Goldstein RS.
    Lancet; 2003 May 10; 361(9369):1652; author reply 1652-3. PubMed ID: 12747904
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
    Hackam DG.
    CMAJ; 2003 May 13; 168(10):1296-7. PubMed ID: 12743078
    [No Abstract] [Full Text] [Related]

  • 38. Prevention of death in COPD.
    La Vecchia C, Fabbri LM.
    N Engl J Med; 2007 May 24; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract] [Full Text] [Related]

  • 39. [Right and wrong of salmeterol/fluticasone propionate combination].
    Sagara H.
    Arerugi; 2006 Jul 24; 55(7):794-810. PubMed ID: 16883107
    [Abstract] [Full Text] [Related]

  • 40. Prevention of death in COPD.
    Kupfer Y, Tessler S.
    N Engl J Med; 2007 May 24; 356(21):2212-3; author reply 2213-4. PubMed ID: 17526086
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.